Compare TEVA & IOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | IOT |
|---|---|---|
| Founded | 1901 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 22.8B |
| IPO Year | N/A | 2021 |
| Metric | TEVA | IOT |
|---|---|---|
| Price | $28.38 | $45.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $27.00 | ★ $49.90 |
| AVG Volume (30 Days) | ★ 11.4M | 5.4M |
| Earning Date | 11-05-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $16,776,000,000.00 | $1,520,629,000.00 |
| Revenue This Year | $4.74 | $27.68 |
| Revenue Next Year | $0.48 | $20.63 |
| P/E Ratio | $46.12 | ★ N/A |
| Revenue Growth | 0.02 | ★ 28.96 |
| 52 Week Low | $12.47 | $31.40 |
| 52 Week High | $28.68 | $61.90 |
| Indicator | TEVA | IOT |
|---|---|---|
| Relative Strength Index (RSI) | 80.93 | 73.46 |
| Support Level | $24.01 | $36.88 |
| Resistance Level | $26.96 | $38.47 |
| Average True Range (ATR) | 0.68 | 1.85 |
| MACD | 0.19 | 0.72 |
| Stochastic Oscillator | 94.65 | 82.90 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows.. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers ranges from small and medium-sized businesses to state and local governments.